What is Dr. Mogire's position on Peter Attia's cardiovascular content?

Peter Attia produced some of the most technically rigorous cardiovascular prevention content in the consumer health space before the events of early 2026, his work on ApoB, CAC scoring, and cardiovascular risk stratification is genuinely excellent in its clinical accuracy. His book Outlive provides a serious framework for longevity medicine that treats cardiovascular prevention with the depth it deserves. SDE builds on, not against, the clinical content he produced that is well-supported.

The documented February 2026 findings, his name appearing in Epstein flight logs, the subsequent severing of his relationships with AG1 and CBS, the NYT assessment of his position in the health content landscape, are a matter of public record and affect his moral authority in a space where trust is a prerequisite for clinical influence. (NYT, February 7, 2026) SDE's position: the clinical science he produced on ApoB and CAC that is evidence-grounded remains clinically accurate. The trust relationship that allowed him to influence millions of men's health decisions has been materially changed by findings he has not publicly addressed. Those are separate assessments, and they are both relevant.

What to do: Evaluate Attia's clinical content on its evidence merits, which are largely strong where he cites primary sources and calibrates his confidence appropriately. Evaluate his moral authority separately, with the awareness that trust and accuracy are different things.

For the full picture, read The Mogire Cardiac Risk Audit.